Updates
OCI SUPPORTS PDG TRACING EFFORT
OCI strongly supports and encourages the work undertaken by PDG in developing, advancing, and sustaining the effective and efficient model for interoperable tracing and verification of prescription pharmaceuticals as required by the DSCSA.
OCI article published in Pharmaceutical Commerce, June issue
Closing a Key Gap in DSCSA Compliance - An article about the origin, purpose and our work at OCI.
OCI Closes U.S. DSCSA Compliance Gap with an Industry-First
OCI invites pharmaceutical supply chain actors into its Early Adopter Program to trial the industry’s first compliance solution for U.S. DSCSA Authorized Trading Partner authentication. The launch of the program now makes the industry’s first functional, scalable solution widely available enabling U.S. supply chain actors to become DSCSA-compliant well ahead of the deadline.
Open Credentialing Initiative (OCI) Gains Momentum Supporting DSCSA Compliance for Authorized Trading Partners
OCI, a collaborative industry effort, issued a call for the pharmaceutical industry to align on core standards around Authorized Trading Partner (ATP) authentication in compliance with the Drug Supply Chain Security Act (DSCSA). Formed by a group of trading partners, solution providers, and standards organizations, OCI is charting the course for ATP interoperability by 2023.